|Written by Rob Goldman|
The most successful way to play the current, difficult market is via certain themes. For example, the 3 latest picks in last month’s 30-30 Report, are up an average of 8% versus the nearly 10% decline during the same period. (Subscribe now to ride the wave of these 3 picks and get our next issue to be released on Thursday.)
Why? Our theme was finding cheap stocks that are seasonal and typically beat estimates. In addition to following this theme we highlight a stock that may be riding the coattails of the Zika virus fears and recommend small stocks in two other sectors.
Worried the bottom could fall out of the market? So are we. In fact, we could drop another 10%. But, see why our confidence is greater that the worst may be over…
DID WE JUST HIT BOTTOM?
We may look back at the hit we took on Thursday and say that was the market bottom. After all, stocks rocked the next day, driven largely by a massive increase in oil prices. Of course, we sensed we were getting close to bottom as featured in our lead story in last week’s edition of The Goldman Guide.
Now, the market is indicating a big up day after tremendous rises in Japan, Asian emerging markets and Europe. Plus, Facebook (NASDAQ—FB) results this week could prolong this short term boost. Unfortunately, I fear that we can still drop another 10% from last Friday’s close.
Still, in the grand scheme of things, stocks seem inexpensive (notice I did not say attractive per se). However, when we hit last week’s new low, it was only on a marginally higher increase in volume. Clearly, there are some market watchers who would feel more comfortable sounding the “all-clear” signal if we had a capitulation event. Or, at the least, a drop of that magnitude on bigger volume.
With all of the turmoil around us, there are stocks rising. In fact, our most recent The 30-30 Report picks are up an average of 8% in the past few weeks while stocks are down 8%. While they still appear attractive, there are other plays too.
Top Three Short Term Investing Themes
For example, our 30-30 picks have been successful due to the fact that they are cheap on a P/E basis, have some seasonality to them, and are riding key themes. The way to play stocks that are represented by an index (Russell 2000) that is down 25% from its year high is to think short term and to leverage themes. After all, there is no conviction yet in equities so you don’t want to get caught with your pants down.
One theme has already been played a bit but is primed to stay with us for a while: The Zika Virus. On page 3 we have a link to a great story on the opportunities here stock-wise. The bottom line is that investors can ride the coattails of stocks like vaccine maker Inovio Pharma (NYSE—INO—$6.27). This controversial company has a lot going for it beyond the early Zika vaccine testing potential and is at least worth a look.
Got courage? Small cap and micro cap oil and gas plays (non-fracking exploration and production) could see some more gains if we are right that oil will approach $40 in the next few months.
Finally, stick with consumer (retail) and tech stocks that have a history of beating estimates. Since tech stocks typically have headwinds beginning in May/June, this is the best time to buy, with the intent to sell during mid-late Q2. Prefer longer term holdings? Dividend-paying stocks that yield more than 2.5% annually are gaining momentum.
Great info, insights, and hard-hitting stories make up this week’s Say What? feature...
More on this later. Got legs don’t you think?
Something to sock away for future investing reference.
The New York Times
What the smart money is doing…
With Clinton slumping, good to know…
A calming influence?
The Stock Market Today
AAII Sentiment Survey (figures rounded)
Believe it or not, the survey results for Bulls and Bears are just a tad above the recent highs achieved in January. Perhaps another drop would represent the “throw in the towel” sentiment. Unfortunately, with the way the week is shaping up, these figures are more likely to climb then descend.
Meanwhile, how funny is it that the Bulls and Neutrals flip-flopped! I feel a consensus among individuals and pros building and that is a good sign.
1498 Reisterstown Road, Suite 286 Baltimore Maryland 21208 Phone: 410.609.7100
[email protected] www.goldmanresearch.com
Launched in May 2010, The Goldman Guide is a free weekly publication of Goldman Small Cap Research and is written by Founder Rob Goldman with contributions from the GSCR contributor team. This non-sponsored investment newsletter seeks to provide investors with market, economic, political and equity-specific insights via an action-oriented, straight to the point approach. No companies mentioned in this newsletter are current sponsored research clients of the Company or its parent, unless noted, With some exceptions, all companies or investment ideas mentioned in this publication are publicly traded stocks listed either on the NYSE or the NASDAQ. Goldman Small Cap Research members and contributors’ bios, certifications, and experience can be found on our website: www.goldmanresearch.com
This newsletter was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces non-sponsored and sponsored (paid) investment research. Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.
The Firm’s non-sponsored research publications category, Select Research, reflects the Firm’s internally generated stock ideas, along with economic, industry and market outlooks. In virtually all cases, stocks mentioned in Select Research offerings are listed on the NYSE or the NASDAQ. Publications in this category include the weekly newsletter The Goldman Guide, Market Monitor blogs, Special Reports, and premium products such as The 30-30 Report. Goldman Small Cap Research analysts are neither long nor short stocks mentioned in this newsletter.
Opportunity Research reports, updates and Microcap Hot Topics articles reflect sponsored (paid) research but can also include non-sponsored microcap research ideas that typically carry greater risks than those stocks covered in Select Research category. It is important to note that while we may track performance separately, we utilize many of the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in company-specific Opportunity Research reports, updates and articles.
Goldman Small Cap Research has not been compensated for any content in this issue.
All information contained in this newsletter and in our reports were provided by the companies mentioned via news releases, filings, and their websites or generated from our own due diligence. Economic, market data and charts are provided by a variety of sources and are cited upon publication. Stock performance data and information are derived from Yahoo! Finance and other websites or sources, as noted. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, other firms, or other financial news outlets. Goldman Small Cap Research relied solely upon information provided by companies through filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research report, update, article, blog, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. This newsletter does not take into account the investment objectives, financial situation, or particular needs of any particular person. This newsletter does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with the FINRA or with any state securities regulatory authority. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.
Separate from the factual content of our articles about the company featured in this newsletter, we may from time to time include our own opinions about the companies profiled herein, their businesses, markets and opportunities. Any opinions we may offer about the companies are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Such information and the opinions expressed are subject to change without notice.
ALL INFORMATION IN THIS REPORT IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com.